Iterum Therapeutics plc (ITRM)
SEC fundamentals · as filed in 10-Q FY2025, period ended Sep 30, 2025 · updated Oct 7, 2026
as filed in 10-Q FY2025, period ended Sep 30, 2025 · View filings on EDGAR ↗
In its 10-Q for the period ended Sep 30, 2025, Iterum Therapeutics plc reported revenue of $390,000, net income of -$9.0M, and total assets of $32.5M. Every figure below is taken directly from Iterum Therapeutics plc's SEC filings: each links to the source document on EDGAR.
Revenue trend
Revenue · FY2016–FY2021 · as reported
- FY2016 revenue
- $0
- FY2021 revenue
- $0
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2024 | — | -$24.8M |
| FY2023 | — | -$38.4M |
| FY2022 | — | -$44.4M |
| FY2021 | $0 | -$91.6M |
| FY2020 | $0 | -$52.0M |
| FY2019 | $37,000 | -$103.1M |
| FY2018 | $869,000 | -$77.1M |
| FY2017 | $508,000 | -$29.4M |
| FY2016 | $0 | -$13.5M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | Mar 31, 2026 | on EDGAR ↗ |
| 8-K | Mar 27, 2026 | on EDGAR ↗ |
| 8-K | Mar 3, 2026 | on EDGAR ↗ |
| 8-K | Mar 2, 2026 | on EDGAR ↗ |
| 8-K | Feb 18, 2026 | on EDGAR ↗ |
| DEF 14A | Jan 2, 2026 | on EDGAR ↗ |
| 8-K | Dec 12, 2025 | on EDGAR ↗ |
| 8-K | Nov 14, 2025 | on EDGAR ↗ |
| 10-Q | Nov 14, 2025 | on EDGAR ↗ |
| 8-K | Oct 16, 2025 | on EDGAR ↗ |
Balance Sheet
as of Sep 30, 2025 · 10-Q
Income Statement
10-Q (quarterly) · period ended Sep 30, 2025
Per Share & Cash Flow
10-Q (quarterly) · period ended Sep 30, 2025
| EPS (diluted) | $-0.20 | Earnings | source ↗ |
| EPS (basic) | $-0.20 | Earnings | source ↗ |
| Shares Outstanding | 44.7M | Entity | source ↗ |
| Cash from Operations | -$7.4M | Net | source ↗ |
| Cash from Financing | $5.4M | Net | source ↗ |
| Cash from Investing | -$12,000 | Net | source ↗ |
Restatement history
Point-in-time4 of 204 annual fact-keys were materially restated between filings: what Iterum Therapeutics plc first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.
See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.
Deeper fundamentals
A free API key reaches ITRM’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/ITRM
MCP tool:
get_sec_fundamentals ticker=ITRM - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/ITRM/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=ITRM as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/ITRM/history
MCP tool:
get_fundamentals_history ticker=ITRM - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/ITRM
MCP tool:
get_financial_health ticker=ITRM
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.